Effect of transcutaneous posterior tibial nerve stimulation and repetitive transcranial magnetic stimulation on neurogenic overactive bladder symptoms in female patients with multiple sclerosis: The study protocol of a randomized controlled study

Pinar Atak Çakir, Fatma Mutluay, Lütfü Hanoğlu, Vahit Güzelburç, Pinar Atak Çakir, Fatma Mutluay, Lütfü Hanoğlu, Vahit Güzelburç

Abstract

Introduction: Neurogenic bladder is frequently seen in patients with multiple sclerosis (MS). Electrical stimulation methods (neuromodulation) can be used for patients that have persistent symptoms despite pharmacological treatment. This study aims to compare the effects of two different neuromodulation techniques used in the treatment of neurogenic bladder.

Methods and analysis: This is a single-center randomized controlled trial for MS patients with neurogenic bladder. Patients determined to be eligible according to the study criteria will be randomized into two treatment groups: the transcutaneous posterior tibial nerve stimulation (PTNS) and repetitive transcranial magnetic stimulation (rTMS) groups. Each group will include eight patients. The patients will be treated for a total of 10 sessions for two consecutive weeks. The pressure-flow study will be used to compare the initial and final urodynamic results as the primary outcome. All the participants will fill in a 3-day bladder diary before and after the treatments in each group. Patients will also be asked to complete specific questionnaires for incontinence and quality of life (QOL): Overactive Bladder Questionnaire-V8 score (OAB-V8), Incontinence Severity Index (ISI), Incontinence Quality of Life Scale score (I-QOL), International Incontinence Questionnaire (ICIQ-SF) score, and International Consultation on Incontinence Questionnaire-Female Lower Urinary Tract Symptoms (ICIQ-FLUTS) score) as the secondary outcomes.

Ethics and dissemination: An ethical approval number was obtained from the Non-Invasive Clinical Research Ethics Committee of Istanbul Medipol University (ethical approval number: 768). Support was received within the scope of the Istanbul Medipol University Scientific Research Project with project number 2020-2017. The result of this study will be published in a peer-reviewed journal.

Trial registration: NCT05312138.

Keywords: PTNS; bladder; multiple sclerosis; neuromodulation; rTMS.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Atak Çakir, Mutluay, Hanoğlu and Güzelburç.

References

    1. Lassmann H, Brück W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol. (2007) 17:210–8. 10.1111/j.1750-3639.2007.00064.x
    1. Hemmett L, Holmes J, Barnes M, Russell N. What drives quality of life in multiple sclerosis? QJM. (2004) 97:671–6. 10.1093/qjmed/hch105
    1. Gunduz B, Erhan B, Demir Y, Coskun E, Tekin N. Neurogenic bladder in multiple sclerosis. Turk J Phys Med Rehab. (2006) 52:102–4.
    1. Fingerman S, Finkelstein H. The overactive bladder in multiple sclerosis. J Am Osteopath Assoc. (2000) 3:9–12.
    1. Al Dandan HB, Coote S, McClurg D. Prevalence of lower urinary tract symptoms in people with multiple sclerosis: a systematic review and meta-analysis. Int J MS Care. (2020) 22:91–9. 10.7224/1537-2073.2019-030
    1. Canbaz Kabay S, Kabay S, Mestan E, Cetiner M, Ayas S, Sevim M, et al. . Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results. Neurourol Urodyn. (2017) 36:104–10. 10.1002/nau.22868
    1. León Ruiz M, Sospedra M, Arce Arce S, Tejeiro-Martínez J, Benito-León J. Current evidence on the potential therapeutic applications of transcranial magnetic stimulation in multiple sclerosis: a systematic review of the literature. Neurologia. (2022) 37:199–215. 10.1016/j.nrleng.2020.05.004
    1. Ellaway PH, Vásquez N, Craggs M. Induction of central nervous system plasticity by repetitive transcranial magnetic stimulation to promote sensorimotor recovery in incomplete spinal cord injury. Front Integr Neurosci. (2014) 20:42. 10.3389/fnint.2014.00042
    1. Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. . Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. (2010) 183:1438–43. 10.1016/j.juro.2009.12.036
    1. Zecca C, Panicari L, Disanto G, Maino P, Singh A, Digesu GA, et al. . Posterior tibial nerve stimulation in the management of lower urinary tract symptoms in patients with multiple sclerosis. Int Urogynecol J. (2016) 27:521–7. 10.1007/s00192-015-2814-6
    1. Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, Sand P, et al. . Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn. (2009) 28:287. 10.1002/nau.20737
    1. Centonze D, Petta F, Versace V, Rossi S, Torelli F, Prosperetti C, et al. . Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis. Mult Scler. (2007) 13:269–71. 10.1177/1352458506070729
    1. Lefaucheur JP, Andre-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, et al. . Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. (2014) 125:2150–206. 10.1016/j.clinph.2014.05.021
    1. Nardone R, Versace V, Sebastianelli L, Brigo F, Golaszewski S, Christova M, et al. . Transcranial magnetic stimulation and bladder function: a systematic review. Neurophysiol Clin. (2019) 130:2032–7. 10.1016/j.clinph.2019.08.020
    1. Gajewski JB, Schurch B, Hamid R, Averbeck M, Sakakibara R, Agrò EF, et al. . An international continence society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn. (2018) 37:1152–61. 10.1002/nau.23397
    1. Tarcan T, Mangir N, Ozgur MO, Akbal C. OAB-V8 overactive bladder questionnaire validation study. Urol Bull. (2012) 21:113–16.
    1. Uyar Hazar H, Sirin A. A validity and reliablity study of the incontinence index. ADU J Fac Med. (2008) 9:5–8.
    1. Ozerdogan N, Kizilkaya NB, Yalcin Ö. Urinary incontinance: its prevalence, risk factors and effects on the quality of life of women living in region of Turkey. Gynecologic Obstet Invest. (2004) 58:145–50. 10.1159/000079422
    1. Kaya S. A comparison of patient characteristics and urinary parameters in women with various types of urinary incontinence: a retrospective study. JETR. (2005) 2:93–101.
    1. Cetinel B, Ozkan B, Can G. The validation study of ICIQ-SF Turkish version. Turk J Urol. (2004) 30:332–8.
    1. Gungor Ugurlucan F, Yasa C, Yuksel Ozgor B, Ayvacikli G, Gunaydin C, Balci BK, et al. . Validation of the Turkish version of the ICIQ-FLUTS, ICIQ-FLUTS long-form, ICIQ-LUTS quality-of-life, and ICIQ-FLUTS sexual functions. Neurourol Urodyn. (2020) 39:962–8. 10.1002/nau.24302
    1. Tran K, Shi Z, Karmonik C, John B, Rajab H, Helekar SA, et al. . Therapeutic effects of non-invasive, individualized, transcranial neuromodulation treatment for voiding dysfunction in multiple sclerosis patients: study protocol for a pilot clinical trial. Pilot Feasibility Stud. (2021) 24:83. 10.1186/s40814-021-00825-z
    1. Abboud H, Hill E, Siddiqui J, Alessandro S, Walter B. Neuromodulation in multiple sclerosis. Mult Scler. (2017) 23:1663–76. 10.1177/1352458517736150
    1. Al Dandan HB, Galvin R, Robinson K, McClurg D, Coote S. Feasibility and acceptability of transcutaneous tibial nerve stimulation for the treatment of bladder storage symptoms among people with multiple sclerosis. Pilot Feasibility Stud. (2022) 30:161. 10.1186/s40814-022-01120-1
    1. Iodice R, Manganelli F, Dubbioso R. The therapeutic use of non-invasive brain stimulation in multiple sclerosis - a review. Restor Neurol Neurosci. (2017) 35:497–509. 10.3233/RNN-170735

Source: PubMed

3
Předplatit